K2 HealthVentures
Parag Shah has a diverse work experience in the healthcare and life sciences industries. Parag is currently the CEO & Founding Managing Director of K2 HealthVentures, a provider of debt and equity capital to venture and growth stage companies. Parag is also the Chairman of eCare Vault, an individualized learning and care coordination platform. Parag has served as an advisor to EIP PHARMA, LLC and as a Charter Member of TiE. Additionally, they have held senior leadership positions at Hercules Technology Growth Capital, Comerica Bank, and BankBoston, where they focused on life sciences and finance. Parag has also served on the board of directors for the Institute for Pediatric Innovation.
Parag Shah's education history begins with their attendance at the Bronx High School of Science from 1985 to 1989. During this time, they did not earn any specific degree or specialize in a particular field of study.
In 1989, Parag Shah went on to pursue a Bachelor of Science (B.S.) degree in Molecular Biology at the Massachusetts Institute of Technology (MIT), completing their studies in 1993.
Seeking further knowledge and expertise, Shah returned to MIT from 1994 to 1996 to complete two different postgraduate degrees. Parag earned a Master of Science (MS) degree in Technology, Management & Policy, emphasizing the intersection of technology and management principles. Additionally, they obtained a Master in City Planning (MCP) degree with a specialization in Environmental Policy & Planning, showcasing their interest in sustainable development and urban planning.
Overall, Parag Shah's educational background includes a B.S. in Molecular Biology, an MS in Technology, Management & Policy, and an MCP in Environmental Policy & Planning, reflecting a diverse range of knowledge and skills in science, technology, management, and environmental studies.
K2 HealthVentures
K2 HealthVentures (K2HV) is an alternative investment firm that provides flexible, long-term financing solutions to innovative private and public companies in the life sciences and healthcare industries. We are healthcare specialists with deep domain expertise, and we understand both the opportunities and challenges that face venture-stage and growth-stage companies. Further, our flat organizational set-up enables nimble decision-making, and our evergreen fund structure allows us to be creative and adapt our facilities to a company’s specific needs over both the short and the long term. Over the last 4 years we have committed more than $1 billion in debt and equity capital to both private and public companies, and our team’s track record spans decades of investing in and supporting innovative life sciences and healthcare companies (with over $4 billion total investments in over 100 portfolio companies).